(S (NP-SBJ-1 (ADJP-COOD (ADJP (JJ Charybdotoxin-sensitive)) (, ,) (ADJP (JJ Ca-LRB-2+-RRB--dependent))) (NN membrane) (JJ potential) (NNS changes)) (VP (VBP are) (RB not) (VP (VBN involved) (NP (-NONE- *-1)) (PP (IN in) (NP (JJ human) (NN T) (CC or) (NN B) (NN cell) (NP-COOD (NP (NN activation)) (CC and) (NP (NN proliferation))))))) (. .))
(S (NP-SBJ-2 (NP (DT The) (NN involvement)) (PP (IN of) (NP (NN ion) (NNS channels))) (PP (IN in) (NP (NN B) (CC and) (NN T) (NN lymphocyte) (NN activation)))) (VP (VBZ is) (VP (VBN supported) (NP (-NONE- *-2)) (PP (IN by) (NP-LGS (NP (JJ many) (NNS reports)) (PP (IN of) (NP (NP (NNS changes)) (PP (IN in) (NP-COOD (NP (NN ion) (NNS fluxes)) (CC and) (NP (NN membrane) (NN potential)))) (PP-TMP (IN after) (NP (NN mitogen) (NN binding))))))))) (. .))
(S (NP-SBJ (JJ Human) (NN T) (CC and) (NN B) (NNS lymphocytes)) (VP (VBP demonstrate) (NP (DT an) (ADJP-COOD (ADJP-TMP (JJ early)) (CC and) (ADJP (JJ transient))) (NN hyperpolarization)) (PP-TMP (IN after) (NP (JJ ligand) (NN binding)))) (. .))
(S (SBAR-ADV (RB Inasmuch) (IN as) (S (NP-SBJ (NP (DT the) (NN change)) (PP (IN in) (NP (NN membrane) (NN potential)))) (VP (VBZ is) (ADJP-PRD (JJ dependent) (PP (IN on) (NP (NP (NN elevation)) (PP (IN of) (NP (JJ free) (JJ cytosolic) (NN calcium))))))))) (, ,) (NP-SBJ (DT the) (NN hyperpolarization)) (VP (VBZ is) (ADVP (RB presumably)) (PP-PRD (IN through) (NP (NP (NN opening)) (PP (IN of) (NP (JJ Ca-LRB-2+-RRB--stimulated) (NN K+) (NNS channels)))))) (. .))
(S (NP-SBJ-3 (PRP We)) (VP (VBP have) (VP (VBN used) (NP (NP (NN charybdotoxin)) (, ,) (NP (NP (DT a) (JJ known) (NN inhibitor)) (PP (IN of) (NP (JJ Ca-LRB-2+-RRB--dependent) (NN K+) (NNS channels)))) (, ,)) (S (NP-SBJ (-NONE- *-3)) (VP (TO to) (VP (VB study) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (DT these) (NNS channels))) (PP (IN in) (NP (NN lymphocyte) (NP-COOD (NP (NN activation)) (CC and) (NP (NN mitogenesis))))))))))) (. .))
(S (NP-SBJ (PRP We)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP-SBJ-4 (NN charybdotoxin)) (VP (VBZ inhibits) (NP (NP (DT the) (JJ ligand-induced) (JJ transient) (NN membrane) (NN hyperpolarization)) (PP (IN in) (NP (NP-COOD (NP (NN B)) (CC and) (NP (NN T))) (NNS cells)))) (PP (IN in) (NP (DT a) (JJ dose-dependent) (NN fashion))) (, ,) (PP (IN without) (S (NP-SBJ (-NONE- *-4)) (VP (VBG affecting) (NP (NP (NNS changes)) (PP (IN in) (NP (JJ cytosolic) (NN Ca2+))))))))))) (. .))
(S (ADVP (RB However)) (, ,) (NP-SBJ-5 (NP (NN blockade)) (PP (IN of) (NP (DT the) (JJ Ca-LRB-2+-RRB--activated) (NN K+) (NN channel)))) (VP (VBZ is) (RB not) (VP (VBN associated) (NP (-NONE- *-5)) (PP (IN with) (NP (NP (NNS changes)) (PP (IN in) (NP-COOD (NP (JJ cell-cycle) (NN gene) (NN activation)) (, ,) (NP (NN IL-2) (NN production)) (, ,) (NP (NN IL-2R) (NN expression)) (CC or) (NP (NP-COOD (NP (NN B)) (CC and) (NP (NN T))) (NN cell) (NN mitogenesis)))))))) (. .))
(S (NP-SBJ (DT These) (NNS results)) (VP (VBP imply) (SBAR (IN that) (S (NP-SBJ-6 (NP (NN membrane) (JJ potential) (NNS changes)) (ADJP (JJ secondary) (PP (TO to) (NP (NP (DT the) (JJ ligand-dependent) (NN opening)) (PP (IN of) (NP (JJ Ca-LRB-2+-RRB--activated) (NN K+) (NNS channels))))))) (VP (VBP are) (RB not) (VP (VBN involved) (NP (-NONE- *-6)) (PP (IN in) (NP (NP (NP-COOD (NP (NN B)) (CC and) (NP (NN T))) (NN lymphocyte)) (NP-COOD (NP (NN activation)) (CC and) (NP (NN mitogenesis)))))))))) (. .))
